Target Price | $218.39 |
Price | $156.06 |
Potential | 39.94% |
Number of Estimates | 57 |
57 Analysts have issued a price target Alphabet 2026 . The average Alphabet target price is $218.39. This is 39.94% higher than the current stock price. The highest price target is $250.00 60.19% , the lowest is $184.00 17.90% . | |
A rating was issued by 67 analysts: 54 Analysts recommend Alphabet to buy, 13 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Alphabet stock has an average upside potential 2026 of 39.94% . Most analysts recommend the Alphabet stock at Purchase. |
56 Analysts have issued a sales forecast Alphabet 2025 . The average Alphabet sales estimate is $390b . This is 11.39% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $400b 14.34% , the lowest is $381b 8.91% .
This results in the following potential growth metrics:
2024 | $350b | 13.89% |
---|---|---|
2025 | $390b | 11.39% |
2026 | $433b | 11.04% |
2027 | $480b | 10.86% |
2028 | $527b | 9.78% |
2029 | $600b | 13.99% |
35 Analysts have issued an Alphabet EBITDA forecast 2025. The average Alphabet EBITDA estimate is $173b . This is 34.14% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $180b 39.66% , the lowest is $165b 28.04% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $127b | 29.97% |
---|---|---|
2025 | $173b | 35.58% |
2026 | $197b | 13.97% |
2027 | $219b | 11.35% |
2028 | $260b | 18.51% |
2029 | $300b | 15.54% |
2024 | 36.45% | 14.13% |
---|---|---|
2025 | 44.36% | 21.71% |
2026 | 45.53% | 2.64% |
2027 | 45.73% | 0.44% |
2028 | 49.36% | 7.94% |
2029 | 50.03% | 1.36% |
60 Alphabet Analysts have issued a net profit forecast 2025. The average Alphabet net profit estimate is $109b . This is 10.88% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $121b 22.86% , the lowest is $98.5b 0.25% .
This results in the following potential growth metrics and future Net Margins:
2024 | $98.2b | 38.62% |
---|---|---|
2025 | $109b | 11.02% |
2026 | $125b | 14.57% |
2027 | $144b | 15.51% |
2028 | $161b | 11.40% |
2029 | $200b | 24.49% |
2024 | 28.07% | 21.72% |
---|---|---|
2025 | 27.97% | 0.34% |
2026 | 28.86% | 3.18% |
2027 | 30.07% | 4.19% |
2028 | 30.51% | 1.46% |
2029 | 33.32% | 9.21% |
60 Analysts have issued a Alphabet forecast for earnings per share. The average Alphabet EPS is $8.93 . This is 10.93% higher than earnings per share in the financial year 2024. The highest EPS forecast is $9.89 22.86% , the lowest is $8.07 0.25% .
This results in the following potential growth metrics and future valuations:
2024 | $8.04 | 38.62% |
---|---|---|
2025 | $8.93 | 11.07% |
2026 | $10.23 | 14.56% |
2027 | $11.81 | 15.44% |
2028 | $13.16 | 11.43% |
2029 | $16.38 | 24.47% |
Current | 19.40 | 25.78% |
---|---|---|
2025 | 17.48 | 9.90% |
2026 | 15.26 | 12.70% |
2027 | 13.21 | 13.43% |
2028 | 11.86 | 10.22% |
2029 | 9.53 | 19.65% |
Based on analysts' sales estimates for 2025, the Alphabet stock is valued at an EV/Sales of 4.71 and an P/S ratio of 4.88 .
This results in the following potential growth metrics and future valuations:
Current | 5.25 | 10.71% |
---|---|---|
2025 | 4.71 | 10.30% |
2026 | 4.24 | 9.94% |
2027 | 3.83 | 9.80% |
2028 | 3.48 | 8.91% |
2029 | 3.06 | 12.27% |
Current | 5.44 | 11.48% |
---|---|---|
2025 | 4.88 | 10.22% |
2026 | 4.40 | 9.95% |
2027 | 3.97 | 9.80% |
2028 | 3.61 | 8.91% |
2029 | 3.17 | 12.27% |
Analyst | Rating | Action | Date |
---|---|---|---|
Citizens Capital Markets |
Market Perform
➜
Market Perform
|
Unchanged | Mar 28 2025 |
Rosenblatt |
Neutral
➜
Neutral
|
Unchanged | Mar 19 2025 |
Roth MKM |
Buy
➜
Buy
|
Unchanged | Mar 19 2025 |
Cantor Fitzgerald |
Neutral
➜
Neutral
|
Unchanged | Mar 19 2025 |
Keybanc |
Overweight
➜
Overweight
|
Unchanged | Mar 18 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Feb 05 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Feb 05 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Citizens Capital Markets:
Market Perform
➜
Market Perform
|
Mar 28 2025 |
Unchanged
Rosenblatt:
Neutral
➜
Neutral
|
Mar 19 2025 |
Unchanged
Roth MKM:
Buy
➜
Buy
|
Mar 19 2025 |
Unchanged
Cantor Fitzgerald:
Neutral
➜
Neutral
|
Mar 19 2025 |
Unchanged
Keybanc:
Overweight
➜
Overweight
|
Mar 18 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Feb 05 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Feb 05 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.